4.7 Article

Skeletal Muscle Mitochondrial Capacity and Insulin Resistance in Type 2 Diabetes

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 96, Issue 4, Pages 1160-1168

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2010-1621

Keywords

-

Funding

  1. Novartis
  2. Takeda Pharmaceuticals North America
  3. NIH [1R01AG030226-01A2]
  4. PBRC Clinical Nutrition Research Unit (CNRU) [NIH P-30-DK072476]
  5. National Institutes of Health [NIH P20-RR021945, NIH 1P30-DK072476]

Ask authors/readers for more resources

Objective: The objective of this study was to determine the role of maximum mitochondrial capacity on the variation in insulin sensitivity within a population of patients with type 2 diabetes mellitus (T2DM). Research Design and Methods: Fifty-eight participants enrolled in a cross-sectional design: eight active controls [maximum aerobic capacity (VO(2max)) > 40 ml/kg . min], 17 healthy sedentary controls without a family history (FH-) and seven with a family history (FH+) of diabetes, four obese participants, and 21 patients with T2DM. Mitochondrial capacity was measured noninvasively using (31)P magnetic resonance spectroscopy of the vastus lateralis. Maximal ATP synthetic rate (ATP(max)) was determined from the rate of phosphocreatine (PCr) recovery after short-term isometric exercise. Results: ATP(max) was lower (P < 0.001) in T2DM and higher (P < 0.001) in active as compared with healthy sedentary FH- (active, 1.01 +/- 0.2; FH-, 0.7 +/- 0.2; FH+, 0.6 +/- 0.1; obese, 0.6 +/- 0.1; T2DM, 0.5 +/- 0.2 mM ATP/sec; ANOVA P < 0.0001). Insulin sensitivity, measured by euglycemic-hyper-insulinemic (80 mIU/m(2) . min) clamp was also reduced in T2DM (P < 0.001) (active, 12.0 +/- 3.2; FH-, 7.8 +/- 2.2; FH+, 6.8 +/- 3.5; obese, 3.1 +/- 1.0; T2DM, 3.4 +/- 1.6; mg/kg estimated metabolic body size . min; ANOVA P < 0.0001). Unexpectedly, there was a broad range of ATP(max) within the T2DM population where 52% of subjects with T2DM had ATP(max) values that were within the range observed in healthy sedentary controls. In addition, 24% of the T2DM subjects overlapped with the active control group (range, 0.65-1.27 mM ATP/sec). In contrast to the positive correlation between ATP(max) and M-value in the whole population (r(2) = 0.35; P < 0.0001), there was no correlation between ATP(max) and M-value in the patients with T2DM (r(2) = 0.004; P = 0.79). Conclusions: Mitochondrial capacity is not associated with insulin action in T2DM.(J Clin Endocrinol Metab 96: 1160-1168, 2011)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available